annual total liabilities:
$24.54M+$11.49M(+88.08%)Summary
- As of today (September 14, 2025), MLTX annual total liabilities is $24.54 million, with the most recent change of +$11.49 million (+88.08%) on December 31, 2024.
- During the last 3 years, MLTX annual total liabilities has risen by +$3.21 million (+15.07%).
- MLTX annual total liabilities is now at all-time high.
Performance
MLTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$102.15M+$3.47M(+3.52%)Summary
- As of today (September 14, 2025), MLTX quarterly total liabilities is $102.15 million, with the most recent change of +$3.47 million (+3.52%) on June 30, 2025.
- Over the past year, MLTX quarterly total liabilities has increased by +$87.31 million (+588.07%).
- MLTX quarterly total liabilities is now -50.61% below its all-time high of $206.82 million, reached on March 31, 2022.
Performance
MLTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MLTX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +88.1% | +588.1% |
| 3 y3 years | +15.1% | +2535.8% |
| 5 y5 years | +491.4% | +10000.0% |
MLTX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +203.9% | at high | +2535.8% |
| 5 y | 5-year | at high | +491.4% | -50.6% | >+9999.0% |
| alltime | all time | at high | +491.4% | -50.6% | >+9999.0% |
MLTX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $102.15M(+3.5%) |
| Mar 2025 | - | $98.68M(+302.1%) |
| Dec 2024 | $24.54M(+88.1%) | $24.54M(+8.1%) |
| Sep 2024 | - | $22.71M(+53.0%) |
| Jun 2024 | - | $14.85M(+26.6%) |
| Mar 2024 | - | $11.73M(-10.1%) |
| Dec 2023 | $13.05M(+61.6%) | $13.05M(+23.4%) |
| Sep 2023 | - | $10.58M(+40.8%) |
| Jun 2023 | - | $7.51M(-2.3%) |
| Mar 2023 | - | $7.68M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $8.08M(-62.1%) | $8.08M(+34.1%) |
| Sep 2022 | - | $6.02M(+55.4%) |
| Jun 2022 | - | $3.88M(-98.1%) |
| Mar 2022 | - | $206.82M(+869.7%) |
| Dec 2021 | $21.33M(+413.9%) | $21.33M(+250.5%) |
| Sep 2021 | - | $6.08M(+47.9%) |
| Jun 2021 | - | $4.12M(+0.7%) |
| Mar 2021 | - | $4.08M(-1.6%) |
| Dec 2020 | $4.15M | $4.15M(+2792.1%) |
| Sep 2020 | - | $143.50K |
FAQ
- What is MoonLake Immunotherapeutics annual total liabilities?
- What is the all time high annual total liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual total liabilities year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly total liabilities year-on-year change?
What is MoonLake Immunotherapeutics annual total liabilities?
The current annual total liabilities of MLTX is $24.54M
What is the all time high annual total liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total liabilities is $24.54M
What is MoonLake Immunotherapeutics annual total liabilities year-on-year change?
Over the past year, MLTX annual total liabilities has changed by +$11.49M (+88.08%)
What is MoonLake Immunotherapeutics quarterly total liabilities?
The current quarterly total liabilities of MLTX is $102.15M
What is the all time high quarterly total liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total liabilities is $206.82M
What is MoonLake Immunotherapeutics quarterly total liabilities year-on-year change?
Over the past year, MLTX quarterly total liabilities has changed by +$87.31M (+588.07%)